ResMed Inc. (LON:0KW4)
London · Delayed Price · Currency is GBP · Price in USD 277.94
+3.56 (1.30%)
At close: Oct 3, 2025
ResMed Employees
ResMed had 10,600 employees as of June 30, 2025. The number of employees increased by 620 or 6.21% compared to the previous year.
Employees
10,600
Change (1Y)
620
Growth (1Y)
6.21%
Revenue / Employee
354.37K GBP
Profits / Employee
96.45K GBP
Market Cap
30.16B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 10,600 | 620 | 6.21% |
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
ResMed News
- 2 days ago - Top 50 High-Quality Dividend Growth Stocks For October 2025 - Seeking Alpha
- 3 days ago - Why ResMed (RMD) is a Top Growth Stock for the Long-Term - Nasdaq
- 10 days ago - Zacks.com featured highlights include GE Aerospace, ResMed, Vertiv and National Fuel Gas - Nasdaq
- 11 days ago - Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns - Nasdaq
- 12 days ago - ResMed Inc. (RMD) Presents at Bank of America Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - ResMed (RMD) Receives 'Buy' Rating from Citigroup with $330 Price Target | RMD Stock News - GuruFocus
- 19 days ago - Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025 - GlobeNewsWire
- 27 days ago - The sleep economy is 'having a moment', says medical equipment firm Resmed - CNBC